Sign inJoin waitlistJoin the waitlist

Ashwin Kishtagari

Physician · Vanderbilt University Medical Center

Credentials: · · ·

History

Vanderbilt University Medical Center
2025–Present

Hematology and Medical Oncology
Cleveland Clinic Foundation
2017–2020
Internal Medicine
Icahn School of Medicine at Mount Sinai
2014–2017
Medical Oncology
Sloan Kettering Cancer Center
2012–2014
KASTURBA MED COLL, MANIPAL, KARNATAKA
2007–2011

Research

Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes
Cell stem cell · 2017 · 725 citations
Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2023 · 188 citations
Driver mutations in acute myeloid leukemia
Review · Current Opinion in Hematology · 2020 · First of 3 authors · 71 citations

Michael Savona
20 papers
Alexander Bick
16 papers
Jaroslaw Maciejewski
11 papers
HA
Hassan Awada
10 papers · 10 as a resident
Sanjay Mohan
9 papers
Alexander Silver
8 papers · 8 as a resident
Hetty Carraway
8 papers
Jonathan Heimlich
8 papers · 6 as a fellow
Mikkael Sekeres
8 papers
BP
Bhumika Patel
7 papers
Brent Ferrell
7 papers
Aziz Nazha
6 papers · 4 as a fellow

Clinical trials

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Site PI · Recruiting · Phase 3
Takeda
2026–2034
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2027
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Site PI · Recruiting · Phase 3
Takeda
2025–2032
Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT Study
Site PI · Recruiting · Phase 2
Uma Borate
2023–2028